Logo image of IEX

IDEX CORP (IEX) Stock Fundamental Analysis

USA - NYSE:IEX - US45167R1041 - Common Stock

166.31 USD
+1.28 (+0.78%)
Last: 10/17/2025, 8:20:32 PM
166.31 USD
0 (0%)
After Hours: 10/17/2025, 8:20:32 PM
Fundamental Rating

6

Overall IEX gets a fundamental rating of 6 out of 10. We evaluated IEX against 130 industry peers in the Machinery industry. IEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IEX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

IEX had positive earnings in the past year.
In the past year IEX had a positive cash flow from operations.
In the past 5 years IEX has always been profitable.
IEX had a positive operating cash flow in each of the past 5 years.
IEX Yearly Net Income VS EBIT VS OCF VS FCFIEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

IEX has a better Return On Assets (6.83%) than 69.23% of its industry peers.
The Return On Equity of IEX (11.70%) is better than 64.62% of its industry peers.
IEX has a Return On Invested Capital of 8.64%. This is in the better half of the industry: IEX outperforms 61.54% of its industry peers.
IEX had an Average Return On Invested Capital over the past 3 years of 10.77%. This is in line with the industry average of 10.01%.
Industry RankSector Rank
ROA 6.83%
ROE 11.7%
ROIC 8.64%
ROA(3y)9.43%
ROA(5y)9.2%
ROE(3y)16.48%
ROE(5y)16.07%
ROIC(3y)10.77%
ROIC(5y)10.86%
IEX Yearly ROA, ROE, ROICIEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

IEX's Profit Margin of 14.05% is amongst the best of the industry. IEX outperforms 86.92% of its industry peers.
IEX's Profit Margin has declined in the last couple of years.
The Operating Margin of IEX (20.87%) is better than 92.31% of its industry peers.
IEX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 44.36%, IEX belongs to the top of the industry, outperforming 83.08% of the companies in the same industry.
IEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.87%
PM (TTM) 14.05%
GM 44.36%
OM growth 3Y-3.35%
OM growth 5Y-2.38%
PM growth 3Y-1.68%
PM growth 5Y-1.96%
GM growth 3Y-0.06%
GM growth 5Y-0.4%
IEX Yearly Profit, Operating, Gross MarginsIEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IEX is creating some value.
The number of shares outstanding for IEX has been increased compared to 1 year ago.
Compared to 5 years ago, IEX has less shares outstanding
IEX has a worse debt/assets ratio than last year.
IEX Yearly Shares OutstandingIEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IEX Yearly Total Debt VS Total AssetsIEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 4.52 indicates that IEX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.52, IEX is in the better half of the industry, outperforming 71.54% of the companies in the same industry.
IEX has a debt to FCF ratio of 3.15. This is a good value and a sign of high solvency as IEX would need 3.15 years to pay back of all of its debts.
IEX has a better Debt to FCF ratio (3.15) than 70.77% of its industry peers.
IEX has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.46, IEX perfoms like the industry average, outperforming 49.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.15
Altman-Z 4.52
ROIC/WACC0.95
WACC9.12%
IEX Yearly LT Debt VS Equity VS FCFIEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

IEX has a Current Ratio of 3.05. This indicates that IEX is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.05, IEX is doing good in the industry, outperforming 77.69% of the companies in the same industry.
IEX has a Quick Ratio of 2.13. This indicates that IEX is financially healthy and has no problem in meeting its short term obligations.
IEX's Quick ratio of 2.13 is fine compared to the rest of the industry. IEX outperforms 77.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 2.13
IEX Yearly Current Assets VS Current LiabilitesIEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

IEX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.65%.
Measured over the past 5 years, IEX shows a small growth in Earnings Per Share. The EPS has been growing by 6.36% on average per year.
The Revenue has been growing slightly by 4.73% in the past year.
IEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.55% yearly.
EPS 1Y (TTM)-1.65%
EPS 3Y7.74%
EPS 5Y6.36%
EPS Q2Q%0.49%
Revenue 1Y (TTM)4.73%
Revenue growth 3Y5.74%
Revenue growth 5Y5.55%
Sales Q2Q%7.21%

3.2 Future

The Earnings Per Share is expected to grow by 9.55% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.21% on average over the next years.
EPS Next Y1.14%
EPS Next 2Y5.02%
EPS Next 3Y6.41%
EPS Next 5Y9.55%
Revenue Next Year5.02%
Revenue Next 2Y4.51%
Revenue Next 3Y5.13%
Revenue Next 5Y7.21%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IEX Yearly Revenue VS EstimatesIEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
IEX Yearly EPS VS EstimatesIEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

IEX is valuated rather expensively with a Price/Earnings ratio of 21.43.
Compared to the rest of the industry, the Price/Earnings ratio of IEX indicates a somewhat cheap valuation: IEX is cheaper than 63.85% of the companies listed in the same industry.
IEX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 19.14, IEX is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IEX is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, IEX is valued at the same level.
Industry RankSector Rank
PE 21.43
Fwd PE 19.14
IEX Price Earnings VS Forward Price EarningsIEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IEX is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, IEX is valued a bit cheaper than the industry average as 65.38% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.33
EV/EBITDA 15.46
IEX Per share dataIEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IEX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of IEX may justify a higher PE ratio.
PEG (NY)18.85
PEG (5Y)3.37
EPS Next 2Y5.02%
EPS Next 3Y6.41%

6

5. Dividend

5.1 Amount

IEX has a Yearly Dividend Yield of 1.72%. Purely for dividend investing, there may be better candidates out there.
IEX's Dividend Yield is a higher than the industry average which is at 1.81.
Compared to the average S&P500 Dividend Yield of 2.36, IEX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

The dividend of IEX is nicely growing with an annual growth rate of 6.95%!
IEX has been paying a dividend for at least 10 years, so it has a reliable track record.
IEX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.95%
Div Incr Years15
Div Non Decr Years29
IEX Yearly Dividends per shareIEX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

IEX pays out 44.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of IEX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP44.84%
EPS Next 2Y5.02%
EPS Next 3Y6.41%
IEX Yearly Income VS Free CF VS DividendIEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
IEX Dividend Payout.IEX Dividend Payout, showing the Payout Ratio.IEX Dividend Payout.PayoutRetained Earnings

IDEX CORP

NYSE:IEX (10/17/2025, 8:20:32 PM)

After market: 166.31 0 (0%)

166.31

+1.28 (+0.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29/amc
Inst Owners105.67%
Inst Owner Change0.13%
Ins Owners0.18%
Ins Owner Change1.77%
Market Cap12.52B
Analysts76.84
Price Target198.41 (19.3%)
Short Float %2.76%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Yearly Dividend2.71
Dividend Growth(5Y)6.95%
DP44.84%
Div Incr Years15
Div Non Decr Years29
Ex-Date10-10 2025-10-10 (0.71)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.49%
Min EPS beat(2)2.89%
Max EPS beat(2)6.08%
EPS beat(4)2
Avg EPS beat(4)2.17%
Min EPS beat(4)-0.18%
Max EPS beat(4)6.08%
EPS beat(8)5
Avg EPS beat(8)3.45%
EPS beat(12)9
Avg EPS beat(12)3.25%
EPS beat(16)12
Avg EPS beat(16)3.41%
Revenue beat(2)0
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-0.39%
Min Revenue beat(4)-1.1%
Max Revenue beat(4)-0.12%
Revenue beat(8)1
Avg Revenue beat(8)-0.79%
Revenue beat(12)4
Avg Revenue beat(12)0.22%
Revenue beat(16)7
Avg Revenue beat(16)0.64%
PT rev (1m)-0.35%
PT rev (3m)-7.28%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-10.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.78%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 21.43
Fwd PE 19.14
P/S 3.75
P/FCF 21.33
P/OCF 19.4
P/B 3.12
P/tB N/A
EV/EBITDA 15.46
EPS(TTM)7.76
EY4.67%
EPS(NY)8.69
Fwd EY5.23%
FCF(TTM)7.8
FCFY4.69%
OCF(TTM)8.57
OCFY5.15%
SpS44.37
BVpS53.28
TBVpS-8.32
PEG (NY)18.85
PEG (5Y)3.37
Profitability
Industry RankSector Rank
ROA 6.83%
ROE 11.7%
ROCE 10.99%
ROIC 8.64%
ROICexc 9.49%
ROICexgc 48.09%
OM 20.87%
PM (TTM) 14.05%
GM 44.36%
FCFM 17.57%
ROA(3y)9.43%
ROA(5y)9.2%
ROE(3y)16.48%
ROE(5y)16.07%
ROIC(3y)10.77%
ROIC(5y)10.86%
ROICexc(3y)11.91%
ROICexc(5y)12.81%
ROICexgc(3y)60.63%
ROICexgc(5y)61.29%
ROCE(3y)13.7%
ROCE(5y)13.82%
ROICexcg growth 3Y-3.1%
ROICexcg growth 5Y-4.49%
ROICexc growth 3Y-11.38%
ROICexc growth 5Y-9.81%
OM growth 3Y-3.35%
OM growth 5Y-2.38%
PM growth 3Y-1.68%
PM growth 5Y-1.96%
GM growth 3Y-0.06%
GM growth 5Y-0.4%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.15
Debt/EBITDA 2.07
Cap/Depr 29.82%
Cap/Sales 1.75%
Interest Coverage 11.41
Cash Conversion 72.29%
Profit Quality 125.05%
Current Ratio 3.05
Quick Ratio 2.13
Altman-Z 4.52
F-Score5
WACC9.12%
ROIC/WACC0.95
Cap/Depr(3y)51%
Cap/Depr(5y)57.05%
Cap/Sales(3y)2.29%
Cap/Sales(5y)2.34%
Profit Quality(3y)102.65%
Profit Quality(5y)110.92%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.65%
EPS 3Y7.74%
EPS 5Y6.36%
EPS Q2Q%0.49%
EPS Next Y1.14%
EPS Next 2Y5.02%
EPS Next 3Y6.41%
EPS Next 5Y9.55%
Revenue 1Y (TTM)4.73%
Revenue growth 3Y5.74%
Revenue growth 5Y5.55%
Sales Q2Q%7.21%
Revenue Next Year5.02%
Revenue Next 2Y4.51%
Revenue Next 3Y5.13%
Revenue Next 5Y7.21%
EBIT growth 1Y-1.01%
EBIT growth 3Y2.2%
EBIT growth 5Y3.04%
EBIT Next Year28.11%
EBIT Next 3Y13.42%
EBIT Next 5Y13.03%
FCF growth 1Y2.98%
FCF growth 3Y6.97%
FCF growth 5Y4.79%
OCF growth 1Y-1.41%
OCF growth 3Y5.73%
OCF growth 5Y4.82%